Balaji Amines Limited has announced its financial results for the quarter and fiscal year ended March 31, 2026. The company reported a steady performance for FY26, supported by stable demand and improved cost efficiencies. The management also provided updates on its strategic expansion projects and future outlook during the earnings conference call held on May 18, 2026.

Financial Performance for Q4 FY26

Consolidated total revenue for Q4 FY26 stood at INR403 crores, compared to INR361 crores in Q4 FY25, registering a year-on-year growth of 12%. Profit after-tax (PAT) for the quarter increased significantly to INR65 crores from INR40 crores in the corresponding period of the previous year.

The company's operational efficiency improved, with consolidated EBITDA rising to INR102 crores from INR68 crores in Q4 FY25. Consequently, the EBITDA margin expanded to 25% in Q4 FY26 from 19% in the previous year. Diluted EPS for the quarter stood at INR19.99 per equity share.

Annual Performance and Balance Sheet

For the full fiscal year FY26, consolidated total revenue reached INR1,454 crores, a slight increase from INR1,430 crores in FY25. Consolidated PAT for the year stood at INR169 crores, reflecting a growth of 7% over INR159 crores in the previous year. The EBITDA margin for FY26 improved to 20% from 19% in FY25.

The company's balance sheet remained robust, with consolidated net worth increasing to INR2,152 crores as of March 2026 from INR2,018 crores in March 2025. Consolidated debt was reported at INR133 crores, primarily attributed to ongoing expansion activities. On a stand-alone basis, the company continues to maintain a zero-debt status.

Operational Highlights and Expansion Updates

Total consolidated sales volume for Q4 FY26 was 27,341 MT, compared to 25,871 MT in Q4 FY25. Management noted that production was briefly impacted in March 2026 due to external geopolitical factors but was managed effectively through inventory planning.

The company provided updates on its key growth projects. The Dimethyl Ether (DME) plant at Unit 4 is expected to be commissioned in Q1 FY27. The N-Methyl Morpholine (NMM) project with a capacity of 5,000 TPA and the improved process Acetonitrile (ACN) plant are also under execution, with commissioning expected during FY27.

Additionally, Balaji Specialty Chemicals Limited is undertaking a major expansion of around INR750 crores. The brownfield project for EDA-based value-added products is slated for commissioning in the first half of FY27, while the greenfield project at MIDC, Chincholi, is expected to be commissioned in Q4 FY27.

Balaji Amines has successfully commissioned its Dimethyl Ether (DME) plant at Unit-IV in Chincholi MIDC, Solapur, commencing commercial production on May 20, 2026. With this development, the company has become the first in India to manufacture DME on a commercial scale, marking a significant milestone in the domestic specialty chemicals sector.

Plant Details and Production Capacity

The newly established facility utilizes advanced technology and has an annual production capacity of 1,00,000 Metric Tonnes. The following table outlines the key parameters of the newly commissioned DME facility:

Strategic Significance and Applications

The commencement of DME production carries notable strategic importance for India's energy sector. DME is recognized as a clean and efficient alternative fuel that can be blended with LPG. The Bureau of Indian Standards (BIS) has recently published a new IS Code permitting DME to be blended with LPG up to 8%. By producing DME domestically, the initiative aligns with broader goals of import substitution and reducing India's reliance on LPG imports.

Initially, Balaji Amines will focus on catering to the aerosol industry and other commercial applications for heating and fuel. The company faced challenges in obtaining statutory approvals, including PESO permissions, due to the absence of adequate Indian Standards, which required the adoption of international standards for storage, handling, and transportation.

Future Outlook in EV Battery Chemicals

Beyond DME, the company is expanding its footprint in the EV battery chemicals space. Management highlighted its strategy to evolve into a major player by repurposing existing plants for new-age chemicals. Key opportunities include:

• Dimethyl Carbonate (DMC) - Electronic Grade: Extensively used in EV battery electrolytes, Balaji Amines is the sole manufacturer in India with an installed capacity of 15,000 MTPA.
• N-Methyl Pyrrolidone (NMP) - Electronic Grade: Manufactured by the company for over two decades, it has now been developed for EV battery grade solvents to serve upcoming Giga Watt capacities.